Intestinal epithelia activate anti-viral signaling via intracellular sensing of rotavirus structural components

Mucosal Immunology

Volumn 3, Issue 6, 2010, Pages 622-632

  Frias, A H ^a,b   Vijay Kumar, M ^a   Gentsch, J R ^c   Crawford, S E ^d   Carvalho, F A ^a   Estes, M K ^d   Gewirtz, A T ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 1; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 3; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 6; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5; NEUTRALIZING ANTIBODY; OLIGOADENYLATE SYNTHETASE 2; PROTEIN KINASE R; PROTEIN MDA 5; PROTEIN MX1; RETINOIC ACID INDUCIBLE PROTEIN I; STAT1 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTERFERON INDUCTION; INTERFERON STIMULATED GENE 15; INTESTINE EPITHELIUM CELL; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; ROTAVIRUS; ULTRAVIOLET RADIATION; VIRUS ENTRY; VIRUS INACTIVATION; VIRUS LIKE AGENT; VIRUS REPLICATION;

EID: 77958196261     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2010.39     Document Type: Article

References (40)

1. Glass, R. I. et al. Rotavirus vaccines: current prospects and future challenges. Lancet 368, 323-332 (2006).
2. Parashar, U. D., Hummelman, E. G., Bresee, J. S., Miller, M. A. & Glass, R. I. Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis. 9, 565-572 (2003).
3. Anderson, E. J. & Weber, S. G. Rotavirus infection in adults. Lancet Infect. Dis. 4, 91-99 (2004).
4. Greenberg, H. B. & Estes, M. K. Rotaviruses: from pathogenesis to vaccination. Gastroenterology 136, 1939-1951 (2009).
5. Jayaram, H., Estes, M. K. & Prasad, B. V. Emerging themes in rotavirus cell entry, genome organization, transcription and replication. Virus Res. 101, 67-81 (2004).
6. Riepenhoff-Talty, M., Dharakul, T., Kowalski, E., Michalak, S. & Ogra, P. L. Persistent rotavirus infection in mice with severe combined immunodeficiency. J. Virol. 61, 3345-3348 (1987).
7. Franco, M. A. & Greenberg, H. B. Immunity to rotavirus in T cell deficient mice. Virology 238, 169-179 (1997).
8. Eiden, J., Lederman, H. M., Vonderfecht, S. & Yolken, R. T-cell-deficient mice display normal recovery from experimental rotavirus infection. J. Virol. 57, 706-708 (1986).
9. Sheth, R. et al. Rotavirus stimulates IL-8 secretion from cultured epithelial cells. Virology 221, 251-259 (1996).
10. Casola, A. et al. Rotavirus infection of cultured intestinal epithelial cells induces secretion of CXC and CC chemokines. Gastroenterology 114, 947-955 (1998).
11. Rollo, E. E. et al. The epithelial cell response to rotavirus infection. J. Immunol. 163, 4442-4452 (1999).
12. Cuadras, M. A., Feigelstock, D. A., An, S. & Greenberg, H. B. Gene expression pattern in Caco-2 cells following rotavirus infection. J. Virol. 76, 4467-4482 (2002).
13. Bass, D. M. Interferon gamma and interleukin 1, but not interferon alfa, inhibit rotavirus entry into human intestinal cell lines. Gastroenterology 113, 81-89 (1997).
14. Lecce, J. G., Cummins, J. M. & Richards, A. B. Treatment of rotavirus infection in neonate and weanling pigs using natural human interferon alpha. Mol. Biother. 2, 211-216 (1990).
15. Schwers, A., Vanden Broecke, C., Maenhoudt, M., Beduin, J. M., Werenne, J. & Pastoret, P. P. Experimental rotavirus diarrhoea in colostrum-deprived newborn calves: assay of treatment by administration of bacterially produced human interferon (Hu-IFN alpha 2). Ann. Rech. Vet. 16, 213-218 (1985).
16. Wang, Y. et al. Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea. J. Virol. 81, 3904-3912 (2007).
17. Barro, M. & Patton, J. T. Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc. Natl. Acad. Sci. USA 102, 4114-4119 (2005).
18. Barro, M. & Patton, J. T. Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7. J. Virol. 81, 4473-4481 (2007).
19. Feng, N. et al. Role of interferon in homologous and heterologous rotavirus infection in the intestines and extraintestinal organs of suckling mice. J. Virol. 82, 7578-7590 (2008).
20. Vancott, J. L., McNeal, M. M., Choi, A. H. & Ward, R. L. The role of interferons in rotavirus infections and protection. J. Interferon Cytokine Res. 23, 163-170 (2003).
21. He, B. Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ. 13, 393-403 (2006).
22. Zeng, H. et al. Flagellin is the major proinflammatory determinant of enteropathogenic Salmonella. J. Immunol. 171, 3668-3674 (2003).
23. Gewirtz, A. T. Intestinal epithelial toll-like receptors: to protect. And serve? Curr. Pharm. Des. 9, 1-5 (2003).
24. Vijay-Kumar, M. et al. Protein kinase R mediates intestinal epithelial gene remodeling in response to double-stranded RNA and live rotavirus. J. Immunol. 174, 6322-6331 (2005).
25. Estes, M. K., Graham, D. Y. & Mason, B. B. Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J. Virol. 39, 879-888 (1981).
26. Gewirtz, A. T., Siber, A. M., Madara, J. L. & McCormick, B. A. Orchestration of neutrophil movement by intestinal epithelial cells in response to Salmonella typhimurium can be uncoupled from bacterial internalization. Infect. Immun. 67, 608-617 (1999).
27. Ciarlet, M., Crawford, S. E. & Estes, M. K. Differential infection of polarized epithelial cell lines by sialic acid-dependent and sialic acid-independent rotavirus strains. J. Virol. 75, 11834-11850 (2001).
28. Gewirtz, A. T., Navas, T. A., Lyons, S., Godowski, P. J. & Madara, J. L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167, 1882-1885 (2001).
29. Groene, W. S. & Shaw, R. D. Psoralen preparation of antigenically intact noninfectious rotavirus particles. J. Virol. Methods 38, 93-102 (1992).
30. Shaw, R. D., Hempson, S. J. & Mackow, E. R. Rotavirus diarrhea is caused by nonreplicating viral particles. J. Virol. 69, 5946-5950 (1995).
31. Jiang, B. et al. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles. Vaccine 17, 1005-1013 (1999).
32. Vijay-Kumar, M. et al. Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J. Immunol. 180, 8280-8285 (2008).
33. Gerna, G. et al. Isolation and characterization of two distinct human rotavirus strains with G6 specificity. J. Clin. Microbiol. 30, 9-16 (1992).
34. Blutt, S. E. et al. Rotavirus antigenemia in children is associated with viremia. PLoS Med. 4, e121 (2007).
35. Nash, S., Parkos, C., Nusrat, A., Delp, C. & Madara, J. L. In vitro model of intestinal crypt abscess. A novel neutrophil-derived secretagogue activity. J. Clin. Invest. 87, 1474-1477 (1991).
36. Shaw, R. D., Stoner-Ma, D. L., Estes, M. K. & Greenberg, H. B. Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J. Clin. Microbiol. 22, 286-291 (1985).
37. Crawford, S. E., Labbe, M., Cohen, J., Burroughs, M. H., Zhou, Y. J. & Estes, M. K. Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J. Virol. 68, 5945-5952 (1994).
38. Boom, R., Sol, C. J., Salimans, M. M., Jansen, C. L., Wertheim-van Dillen, P. M. & van der Noordaa, J. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28, 495-503 (1990).
39. Gentsch, J. R. et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J. Clin. Microbiol. 30, 1365-1373 (1992).
40. Evans, C. O. et al. Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. J. Clin. Endocrinol. Metab. 86, 3097-3107 (2001).